General Info

CardioNet, headquartered in San Diego, became an operating company in 1999. It was founded on an innovative, patented technology, the result of years of research and development. In the integration of cardiac monitoring, wireless communications, GPS and proprietary information management technologies, the CardioNet mobile outpatient telemetry system is the first to provide real-time electrocardiogram monitoring and year-round analysis and response for patients--at home, at work or traveling. In February 2002, CardioNet received Food and Drug Administration approval for its core monitoring technology and opened the first CardioNet Service Center in Philadelphia. It is a venture-backed company whose investors include Hambrecht & Quist Capital Management, Sanderling, IngleWood Ventures, BioFrontier Partners, IDEO, Guidant Corporation and Foundation Medical Partners.